|
Older and younger chronic leukemia patients may need different therapy
Science Codex “The study suggests that chlorambucil is superior to fludarabine in older patients, and that CD20 antibody therapies such as rituximab are beneficial as front-line therapy for all CLL patients, regardless of age,” says Byrd, who is the D. Warren Brown … |
A bitter bill to swallow, for life
Mumbai, Dec. 13 — For those suffering from lasting diseases such as diabetes and hepatitis, there is no respite from ever-increasing medical costs, and the damage these ailments do to vital organs such as the kidneys and liver often forces patients to…
New Combo Replaces CHOP for Lymphoma – MedPage Today
|
New Combo Replaces CHOP for Lymphoma
MedPage Today ATLANTA – Once the most common treatment for indolent non-Hodgkin’s Lymphoma, the combination chemotherapy known as CHOP is rapidly falling to the wayside in Germany – replaced by bendamustine (Treanda), frequently combined with rituximab … |
Anti–PD-1 Immunotherapy Shows Activity in Relapsed Lymphoma Patients – Cancer Network
|
Anti–PD-1 Immunotherapy Shows Activity in Relapsed Lymphoma Patients
Cancer Network The combination of rituximab (Rituxan) and the novel immunotherapy pidilizumab (CT-011) is both active and well tolerated in follicular lymphoma patients, according to results of a phase II trial presented by Jason R. Westin, MD, of the MD Anderson … |
Older and younger chronic leukemia patients may need different therapy – Medical Xpress
|
Older and younger chronic leukemia patients may need different therapy
Medical Xpress “The study suggests that chlorambucil is superior to fludarabine in older patients, and that CD20 antibody therapies such as rituximab are beneficial as front-line therapy for all CLL patients, regardless of age,” says Byrd, who is the D. Warren Brown … |
CORRECTING AND REPLACING Gencaro(TM) Cardiovascular Effect on … – MarketWatch (press release)
|
CORRECTING AND REPLACING Gencaro(TM) Cardiovascular Effect on …
MarketWatch (press release) ARCA biopharma, Inc. (NASDAQ:ABIO) , a biopharmaceutical company developing genetically-targeted therapies for atrial fibrillation and other cardiovascular diseases, today announced that the paper “Effect of Bucindolol (Gencaro) on Heart Failure … |
Older and Younger Chronic Leukemia Patients May Need Different Therapy – HealthNewsDigest.com
 HealthNewsDigest.com |
Older and Younger Chronic Leukemia Patients May Need Different Therapy
HealthNewsDigest.com “The study suggests that chlorambucil is superior to fludarabine in older patients, and that CD20 antibody therapies such as rituximab are beneficial as front-line therapy for all CLL patients, regardless of age,” says Byrd, who is the D. Warren Brown … |
Rejoice in the music – The Hindu
 The Hindu |
Rejoice in the music
The Hindu “She donated the first organ for the choir and was a pioneer of sorts,” says D. Devakumar, one of the senior organists in the choir. Mrs. Wills stepped down in … Also, it was often invited by the All India Radio to present devotionals. “We do take up … |
Wearable defibrillator use in heart failure (WIF): results of a prospective … – 7thSpace Interactive (press release)
Wearable defibrillator use in heart failure (WIF): results of a prospective …7thSpace Interactive (press release)This includes the newly diagnosed patients, as well as those on the cardiac transplant list or NYHA class IV heart failure patients who d…
Chuck Reynolds
Chuck Reynolds passed away peacefully at UW Hospital in Madison on Thursday, Dec. 6, 2012, with his family beside him. He was a post-heart transplant patient who contracted a fungal pneumonia,…